Weight-loss drugs may cut breast cancer risk by up to 30%, study finds

A recent study suggests that women taking weight-loss drugs could see a significant reduction in their risk of developing breast cancer, with a potential decrease of up to 30%. This finding is crucial as breast cancer remains one of the most common cancers among women globally. Beyond just weight management, these medications might offer a promising preventive benefit, which could influence future treatment and prevention strategies. This insight opens up new avenues for integrating weight-loss therapies into broader cancer prevention plans.